Bernhard Mittemeyer
Corporate Officer/Principal chez Texas Tech University Health Sciences Center
Postes actifs de Bernhard Mittemeyer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Texas Tech University Health Sciences Center | Corporate Officer/Principal | - | - |
Historique de carrière de Bernhard Mittemeyer
Anciens postes connus de Bernhard Mittemeyer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Hemobiotech, Inc.
 Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Directeur/Membre du Conseil | 10/12/2004 | - |
| Independent Dir/Board Member | 10/12/2004 | - |
Formation de Bernhard Mittemeyer
| Temple University (Pennsylvania) | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Hemobiotech, Inc.
Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Health Technology |
- Bourse
- Insiders
- Bernhard Mittemeyer
- Expérience
